{"id":"NCT02324270","sponsor":"Actavis Inc.","briefTitle":"Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain","officialTitle":"Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing the Safety and Efficacy of Generic Diclofenac Epolamine to FlectorÂ® Patch in the Treatment of Acute Pain Due to Minor Ankle Sprain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2014-12-24","resultsPosted":"2020-06-24","lastUpdate":"2020-06-24"},"enrollment":658,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankle Sprain"],"interventions":[{"type":"DRUG","name":"Diclofenac epolamine","otherNames":["Flector Patch"]},{"type":"OTHER","name":"Placebo","otherNames":["Vehicle control"]}],"arms":[{"label":"Diclofenac epolamine","type":"ACTIVE_COMPARATOR"},{"label":"generic diclofenac epolamine patch","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain","primaryOutcome":{"measure":"Visual Analogue Scale (VAS) Scores at Baseline and Post Treatment","timeFrame":"Baseline, 3 days","effectByArm":[{"arm":"Diclofenac Epolamine Patch (Test Product)","deltaMin":68.56,"sd":11.03},{"arm":"Flector (Reference Product)","deltaMin":69.03,"sd":10.9}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":214},"commonTop":["Headache","Application site pruritus","Pruritus","Dizziness","Paraesthesia"]}}